{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:54:01Z","timestamp":1785351241034,"version":"3.55.0"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immunoglobulin A nephropathy (IgAN) is the most prevalent glomerulonephritis in the world, and it is one of the leading causes of end-stage kidney disease. It is now believed that the pathogenesis of IgAN is the mesangial deposition of immune complex containing galactose-deficient IgA1, resulting in glomerular injury. Current treatments for IgAN include supportive care and immunosuppressive therapy. A growing number of studies found that the gut microbiota in IgAN was dysregulated. Gut microbiota may be involved in the development and progression of IgAN through three main aspects: destruction of intestinal barrier, changes in metabolites and abnormal mucosal immunity. Interestingly, therapies by modulating the gut microbiota, such as fecal microbiota transplantation, antibiotic treatment, probiotic treatment, Chinese herbal medicine Zhen Wu Tang treatment, gluten-free diet, and hydroxychloroquine treatment, can improve IgAN. In this review, the alteration of gut microbiota in IgAN, potential pathogenic roles of gut microbiota on IgAN and potential approaches to treat IgAN by modulating the gut microbiota are summarized.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1438683","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:09:26Z","timestamp":1738825766000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Characteristics, pathogenic and therapeutic role of gut microbiota in immunoglobulin A nephropathy"],"prefix":"10.3389","volume":"16","author":[{"given":"Kaijin","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yina","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","article-title":"IgA nephropathy","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis primers."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrology dialysis transplantation: Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000108755","article-title":"Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China","volume":"28","author":"Xie","year":"2008","journal-title":"Am J nephrology."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07420716","article-title":"IgA nephropathy","volume":"12","author":"Rodrigues","year":"2017","journal-title":"Clin J Am Soc Nephrology: CJASN."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrology: JASN."},{"key":"B6","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis primers."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00888-3","article-title":"Current treatment of IgA nephropathy","volume":"43","author":"Floege","year":"2021","journal-title":"Semin immunopathology."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1681\/ASN.2016060647","article-title":"Corticosteroids in igA nephropathy: lessons from recent studies","volume":"28","author":"Coppo","year":"2017","journal-title":"J Am Soc Nephrology: JASN."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.117","article-title":"Probiotics and the gut microbiota in intestinal health and disease","volume":"7","author":"Gareau","year":"2010","journal-title":"Nat Rev Gastroenterol hepatology."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nri2710","article-title":"Immune adaptations that maintain homeostasis with the intestinal microbiota","volume":"10","author":"Hooper","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J gastroenterology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12967-018-1756-4","article-title":"Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease","volume":"17","author":"Chen","year":"2019","journal-title":"J Trans Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-016-3527-x","article-title":"The gut-kidney axis","volume":"32","author":"Evenepoel","year":"2017","journal-title":"Pediatr Nephrol (Berlin Germany)."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.993716","article-title":"Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation","volume":"10","author":"Luvizotto","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00893-6","article-title":"The microbiome and IgA nephropathy","volume":"43","author":"Haniuda","year":"2021","journal-title":"Semin immunopathology."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.823267","article-title":"Gut microbes in immunoglobulin A nephropathy and their potential therapeutic applications","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.606689","article-title":"Integrated fecal microbiome and serum metabolomics analysis reveals abnormal changes in rats with immunoglobulin A nephropathy and the intervention effect of zhen wu tang","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12967-022-03585-3","article-title":"Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling","volume":"20","author":"Tan","year":"2022","journal-title":"J Trans Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.21037\/atm-20-2506","article-title":"Identification of a novel interplay between intestinal bacteria and metabolites in Chinese patients with IgA nephropathy via integrated microbiome and metabolome approaches","volume":"9","author":"Wu","year":"2021","journal-title":"Ann Trans Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.970723","article-title":"Metagenomics-based systematic analysis reveals that gut microbiota Gd-IgA1-associated enzymes may play a key role in IgA nephropathy","volume":"9","author":"Liang","year":"2022","journal-title":"Front Mol biosciences."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1059692","article-title":"Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes","volume":"12","author":"Dong","year":"2022","journal-title":"Front Cell infection Microbiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.19723\/j.issn.1671-167X.2023.01.019","article-title":"Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors","volume":"55","author":"Bao","year":"2023","journal-title":"Beijing da xue xue bao Yi xue ban = J Peking Univ Health Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022020189","article-title":"Expansion of escherichia-shigella in gut is associated with the onset and response to immunosuppressive therapy of igA nephropathy","volume":"33","author":"Zhao","year":"2022","journal-title":"J Am Soc Nephrology: JASN."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000528973","article-title":"Aberrant gut microbiome contributes to barrier dysfunction, inflammation, and local immune responses in igA nephropathy","volume":"48","author":"Tang","year":"2023","journal-title":"Kidney Blood Pressure Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"107085","DOI":"10.1016\/j.intimp.2020.107085","article-title":"Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population","volume":"89","author":"Zhong","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.944027","article-title":"Gut dysbiosis and intestinal barrier dysfunction promotes igA nephropathy by increasing the production of gd-igA1","volume":"9","author":"Tang","year":"2022","journal-title":"Front Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12882-021-02315-z","article-title":"Gut microbiota in immunoglobulin A nephropathy: a Malaysian perspective","volume":"22","author":"Sugurmar","year":"2021","journal-title":"BMC nephrology."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099006","article-title":"Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN)","volume":"9","author":"De Angelis","year":"2014","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00819-20","article-title":"Associations of genetic variants contributing to gut microbiota composition in immunoglobin A nephropathy","volume":"6","author":"He","year":"2021","journal-title":"mSystems"},{"key":"B31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12882-021-02414-x","article-title":"Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy","volume":"22","author":"Chai","year":"2021","journal-title":"BMC nephrology."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.752393","article-title":"Sex differences in fecal microbiota correlation with physiological and biochemical indices associated with end-stage renal disease caused by immunoglobulin a nephropathy or diabetes","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Microbiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12882-020-01741-9","article-title":"Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study","volume":"21","author":"Hu","year":"2020","journal-title":"BMC nephrology."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.557368","article-title":"A comparative study of the gut microbiota associated with immunoglobulin a nephropathy and membranous nephropathy","volume":"10","author":"Dong","year":"2020","journal-title":"Front Cell infection Microbiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000132021","article-title":"The gut and blood microbiome in igA nephropathy and healthy controls","volume":"2","author":"Shah","year":"2021","journal-title":"Kidney360."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1061629","article-title":"Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease","volume":"12","author":"Hu","year":"2022","journal-title":"Front Cell infection Microbiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.071","article-title":"Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands","volume":"134","author":"de Vries","year":"2008","journal-title":"Gastroenterology."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2020.1772295","article-title":"Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy","volume":"42","author":"Liu","year":"2020","journal-title":"Renal failure."},{"key":"B39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/B978-0-12-394598-3.00005-8","article-title":"Modern approaches in probiotics research to control foodborne pathogens","volume":"67","author":"Amalaradjou","year":"2012","journal-title":"Adv Food Nutr Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1171517","article-title":"Causal effects between gut microbiota and IgA nephropathy: a bidirectional Mendelian randomization study","volume":"13","author":"Ren","year":"2023","journal-title":"Front Cell infection Microbiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.3390\/nu15102407","article-title":"The effects of specific gut microbiota and metabolites on igA nephropathy-based on mendelian randomization and clinical validation","volume":"15","author":"Wang","year":"2023","journal-title":"Nutrients"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3118","article-title":"Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i26.4137","article-title":"Effects of rhein on intestinal epithelial tight junction in IgA nephropathy","volume":"19","author":"Peng","year":"2013","journal-title":"World J gastroenterology."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/path.v257.3","article-title":"Sustained release of Lactobacillus casei cell wall extract can induce a continuous and stable IgA deposition model","volume":"257","author":"Wan","year":"2022","journal-title":"J pathology."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.01.003","article-title":"Manipulating the gut microbiome to decrease uremic toxins","volume":"91","author":"Yacoub","year":"2017","journal-title":"Kidney Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.1991.tb02739.x","article-title":"The control and consequences of bacterial fermentation in the human colon","volume":"70","author":"Cummings","year":"1991","journal-title":"J Appl bacteriology."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2008.04.006","article-title":"Mechanisms for suppression of interleukin-6 expression in peritoneal macrophages from docosahexaenoic acid-fed mice","volume":"20","author":"Shi","year":"2009","journal-title":"J Nutr Biochem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.811526","article-title":"Metabolic dysfunctions of intestinal fatty acids and tryptophan reveal immuno-inflammatory response activation in igA nephropathy","volume":"9","author":"Wu","year":"2022","journal-title":"Front Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2019.1598334","article-title":"Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR)","volume":"60","author":"Sun","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa264","article-title":"High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients","volume":"36","author":"Sallustio","year":"2021","journal-title":"Nephrology dialysis transplantation: Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"New Engl J Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv221","article-title":"Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy","volume":"30","author":"Yasutake","year":"2015","journal-title":"Nephrology dialysis transplantation: Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00871-y","article-title":"The mucosal immune system and IgA nephropathy","volume":"43","author":"Gesualdo","year":"2021","journal-title":"Semin immunopathology."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.08.009","article-title":"Why target the gut to treat igA nephropathy","volume":"5","author":"Barratt","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4735040","DOI":"10.1155\/2019\/4735040","article-title":"Gut microbiota modulation on intestinal mucosal adaptive immunity","volume":"2019","author":"Wang","year":"2019","journal-title":"J Immunol Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-016-0265-x","article-title":"IgA nephropathy and infections","volume":"29","author":"Rollino","year":"2016","journal-title":"J nephrology."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101314","article-title":"Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis","volume":"28","author":"Fagarasan","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/PAP.0000000000000134","article-title":"Pathophysiology of igA nephropathy","volume":"24","author":"Al Hussain","year":"2017","journal-title":"Adv anatomic pathology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1084\/jem.191.11.1999","article-title":"Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger\u2019s disease)","volume":"191","author":"Launay","year":"2000","journal-title":"Evidence pathogenic soluble receptor-Iga complexes patients CD89 Transgenic mice. J Exp Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20112005","article-title":"Transglutaminase is essential for IgA nephropathy development acting through IgA receptors","volume":"209","author":"Berthelot","year":"2012","journal-title":"J Exp Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cellimm.2006.08.002","article-title":"BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHT","volume":"241","author":"McCarthy","year":"2006","journal-title":"Cell Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1172\/JCI45563","article-title":"Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy","volume":"121","author":"McCarthy","year":"2011","journal-title":"J Clin Invest"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015080911","article-title":"IgA structure variations associate with immune stimulations and igA mesangial deposition","volume":"27","author":"Oruc","year":"2016","journal-title":"J Am Soc Nephrology: JASN."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694787","article-title":"Fecal microbiota transplantation modulates renal phenotype in the humanized mouse model of igA nephropathy","volume":"12","author":"Lauriero","year":"2021","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl6149","article-title":"The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis","volume":"16","author":"Gleeson","year":"2024","journal-title":"Sci Trans Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae052","article-title":"IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1via the TLR4 signaling pathway","volume":"39","author":"Zhu","year":"2024","journal-title":"Nephrology dialysis transplantation: Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc"},{"key":"B68","article-title":"Activation of intestinal mucosal TLR4\/NF-\u03baB pathway is associated with renal damage in mice with pseudo-sterile IgA nephropathy","volume":"39","author":"Tang","year":"2023","journal-title":"Xi bao yu fen zi mian yi xue za zhi = Chin J Cell Mol Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01554-4","article-title":"Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial","volume":"402","author":"Lafayette","year":"2023","journal-title":"Lancet (London England)."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179137","article-title":"The protective effects of Zhen-Wu-Tang against cisplatin-induced acute kidney injury in rats","volume":"12","author":"Liu","year":"2017","journal-title":"PloS One"},{"key":"B71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jep.2017.12.013","article-title":"Zhen-wu-tang ameliorates adenine-induced chronic renal failure in rats: regulation of the canonical Wnt4\/beta-catenin signaling in the kidneys","volume":"219","author":"La","year":"2018","journal-title":"J ethnopharmacology."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0439-x","article-title":"The pros, cons, and many unknowns of probiotics","volume":"25","author":"Suez","year":"2019","journal-title":"Nat Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-008-0813-2","article-title":"Saccharomyces boulardii prevents oral-poliovirus vaccine-induced IgA nephropathy in mice","volume":"23","author":"Soylu","year":"2008","journal-title":"Pediatr Nephrol (Berlin Germany)."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy323","article-title":"Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice","volume":"34","author":"Chemouny","year":"2019","journal-title":"Nephrology dialysis transplantation: Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1483333","article-title":"The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn\u2019s disease","volume":"27","author":"Lopetuso","year":"2018","journal-title":"Expert Opin investigational Drugs"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00044","article-title":"Rifaximin alters intestinal microbiota and prevents progression of ankylosing spondylitis in mice","volume":"9","author":"Yang","year":"2019","journal-title":"Front Cell infection Microbiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/jpm11040309","article-title":"Rifaximin as a potential treatment for igA nephropathy in a humanized mice model","volume":"11","author":"Di Leo","year":"2021","journal-title":"J personalized Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2023.2300306","article-title":"Hydroxychloroquine ameliorates immune functionality and intestinal flora disorders of IgA nephropathy by inhibition of C1GALT1\/Cosmc pathway","volume":"46","author":"Wang","year":"2024","journal-title":"Immunopharmacol immunotoxicology."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114509371767","article-title":"Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects","volume":"102","author":"De Palma","year":"2009","journal-title":"Br J Nutr"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.94","article-title":"Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction","volume":"88","author":"Papista","year":"2015","journal-title":"Kidney Int"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2021.1936038","article-title":"Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports","volume":"43","author":"Zhao","year":"2021","journal-title":"Renal failure."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.914250","article-title":"Fecal capsule as a therapeutic strategy in igA nephropathy: A brief report","volume":"9","author":"Zhi","year":"2022","journal-title":"Front Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-111717-122956","article-title":"Clinical application and potential of fecal microbiota transplantation","volume":"70","author":"Ooijevaar","year":"2019","journal-title":"Annu Rev Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1438683\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:09:31Z","timestamp":1738825771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1438683\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":83,"alternative-id":["10.3389\/fimmu.2025.1438683"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1438683","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"article-number":"1438683"}}